132 related articles for article (PubMed ID: 27495938)
1. Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS.
Islamov RR; Rizvanov AA; Fedotova VY; Izmailov AA; Safiullov ZZ; Garanina EE; Salafutdinov II; Sokolov ME; Mukhamedyarov MA; Palotás A
Mol Neurobiol; 2017 Aug; 54(6):4756-4763. PubMed ID: 27495938
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.
Islamov RR; Izmailov AA; Sokolov ME; Fadeev PO; Bashirov FV; Eremeev AA; Shaymardanova GF; Shmarov MM; Naroditskiy BS; Chelyshev YA; Lavrov IA; Palotás A
Brain Res Bull; 2017 Jun; 132():44-52. PubMed ID: 28529158
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion.
Mukhamedshina YO; Garanina EE; Masgutova GA; Galieva LR; Sanatova ER; Chelyshev YA; Rizvanov AA
PLoS One; 2016; 11(3):e0151745. PubMed ID: 27003408
[TBL] [Abstract][Full Text] [Related]
7. Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.
Povysheva T; Shmarov M; Logunov D; Naroditsky B; Shulman I; Ogurcov S; Kolesnikov P; Islamov R; Chelyshev Y
J Neurosurg Spine; 2017 Jul; 27(1):105-115. PubMed ID: 28452633
[TBL] [Abstract][Full Text] [Related]
8. Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.
Garanina EE; Mukhamedshina YO; Salafutdinov II; Kiyasov AP; Lima LM; Reis HJ; Palotás A; Islamov RR; Rizvanov AA
Spinal Cord; 2016 Jun; 54(6):423-30. PubMed ID: 26439843
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype.
Mukhamedyarov MA; Rizvanov AA; Safiullov ZZ; Izmailov AA; Sharifullina GA; Solovieva VV; Fedotova VY; Salafutdinov II; Cherenkova EE; Bashirov FV; Kaligin MS; Abdulkhakov SR; Shmarov MM; Logunov DY; Naroditsky BS; Kiyasov AP; Zefirov AL; Islamov RR
Bull Exp Biol Med; 2013 Feb; 154(4):558-61. PubMed ID: 23486603
[TBL] [Abstract][Full Text] [Related]
10. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of cell-mediated gene therapy for spinal cord injury in mini pigs.
Islamov RR; Sokolov ME; Bashirov FV; Fadeev FO; Shmarov MM; Naroditskiy BS; Povysheva TV; Shaymardanova GF; Yakupov RA; Chelyshev YA; Lavrov IA
Neurosci Lett; 2017 Mar; 644():67-75. PubMed ID: 28213069
[TBL] [Abstract][Full Text] [Related]
12. Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.
Garbuzova-Davis S; Ehrhart J; Sanberg PR
Expert Opin Biol Ther; 2017 Jul; 17(7):837-851. PubMed ID: 28443372
[TBL] [Abstract][Full Text] [Related]
13. Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion.
Izmailov AA; Povysheva TV; Bashirov FV; Sokolov ME; Fadeev FO; Garifulin RR; Naroditsky BS; Logunov DY; Salafutdinov II; Chelyshev YA; Islamov RR; Lavrov IA
Front Pharmacol; 2017; 8():813. PubMed ID: 29180963
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat.
Mukhamedshina YO; Shaymardanova GF; Garanina ЕЕ; Salafutdinov II; Rizvanov АА; Islamov RR; Chelyshev YA
Spinal Cord; 2016 May; 54(5):347-59. PubMed ID: 26415641
[TBL] [Abstract][Full Text] [Related]
15. Combination of epidural electrical stimulation with
Fadeev FO; Bashirov FV; Markosyan VA; Izmailov AA; Povysheva TV; Sokolov ME; Kuznetsov MS; Eremeev AA; Salafutdinov II; Rizvanov AA; Lee HJ; Islamov RR
Neural Regen Res; 2021 Mar; 16(3):550-560. PubMed ID: 32985487
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of scAAV9-IGF1 extends survival in SOD1
Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
[TBL] [Abstract][Full Text] [Related]
19. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
Chen R; Ende N
J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
[TBL] [Abstract][Full Text] [Related]
20. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
